|
1
|
A recombinant rhesus cytomegalovirus expressing enhanced green fluorescent protein retains the wild-type phenotype and pathogenicity in fetal macaques.
|
J Virol
|
2002
|
1.15
|
|
2
|
Antibody responses to rhesus cytomegalovirus glycoprotein B in naturally infected rhesus macaques.
|
J Gen Virol
|
2003
|
1.10
|
|
3
|
Immunogenicity and protective efficacy of DNA vaccines expressing rhesus cytomegalovirus glycoprotein B, phosphoprotein 65-2, and viral interleukin-10 in rhesus macaques.
|
J Virol
|
2006
|
1.06
|
|
4
|
Nonhuman primate models of intrauterine cytomegalovirus infection.
|
ILAR J
|
2006
|
0.95
|
|
5
|
Characterization and immunological analysis of the rhesus cytomegalovirus homologue (Rh112) of the human cytomegalovirus UL83 lower matrix phosphoprotein (pp65).
|
J Gen Virol
|
2006
|
0.91
|
|
6
|
Rhesus brain microvascular endothelial cells are permissive for rhesus cytomegalovirus infection.
|
J Gen Virol
|
2005
|
0.80
|
|
7
|
Increased circulating Th17 cell populations and elevated CSF osteopontin and IL-17 concentrations in patients with Guillain-Barré syndrome.
|
J Clin Immunol
|
2013
|
0.78
|